StockIQ.techChugai Pharmaceutical Co., Ltd. (4519.T) Stock Analysis
Free AI-powered analysis and research for Chugai Pharmaceutical Co., Ltd. stock
Sector: Healthcare
4519.T snapshot
Data as of 2 Nov 2026 close. Updated daily.
Chugai Pharmaceutical Co., Ltd. scores 74/100 on StockIQ's model, which reads as positive signals overall. The price is below its 200-day average and at 18% of its 52-week range, down 1.5% over the past year. Latest reported figures show a profit margin of 35.6%, return on equity of 25.3% and revenue growth of +21.5%.
What is driving the score
- Mixed Trend: +0
- MACD Bullish: +8
- Strong Revenue Growth (21.5%): +8
- Excellent Profit Margin (35.6%): +10
- Strong Liquidity (6.39 Current Ratio): +8
- Excellent ROE (25.3%): +8
- High P/B (5.24): -5
- Long-term Downtrend: -8
- Underperforming (-1.5% over 1 year): -5
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full 4519.T report
Chugai Pharmaceutical Co., Ltd. (4519.T) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze 4519.T Now →📰 Latest Update
Chugai Pharmaceutical (TSE:4519) Stock Price Trails Strong Q3 Earnings
Thu, October 29, 2026 at 6:28 AM UTC 4 min read
Chugai Pharmaceutical (TSE: 4519) reported strong Q3 earnings, showcasing robust financial performance. Despite the positive results, the stock price has not reflected this growth, leading to investor concerns about market sentiment and potential undervaluation. Investors may want to monitor the stock for possible recovery opportunities, as strong earnings could indicate a solid foundation for future growth.